Real‐world clinical experience with serum MOG and AQP4 antibody testing by live versus fixed cell‐based assay
Abstract Objective To assess the real‐world performance of a live (LCBA) versus a fixed (FCBA) cell‐based assay for the detection of serum antibodies directed against myelin oligodendrocyte glycoprotein (MOG‐IgG) and aquaporin‐4 (AQP4‐IgG). Methods This was a retrospective study of patients evaluate...
Saved in:
| Main Authors: | Yana Said, Angeliki Filippatou, Conlan Tran, LuAnn Rezavi, Kai Guo, Matthew D. Smith, Yasmin Resto, John J. Chen, Peter A. Calabresi, Patrizio Caturegli, Sean J. Pittock, Eoin P. Flanagan, Elias S. Sotirchos |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-03-01
|
| Series: | Annals of Clinical and Translational Neurology |
| Online Access: | https://doi.org/10.1002/acn3.52310 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reply to Letter: Real‐World Clinical Experience With Serum MOG and AQP4 Antibody Testing by Live Versus Fixed Cell‐Based Assay
by: Yana Said, et al.
Published: (2025-08-01) -
Discontinuation of Immunotherapy in Patients With Relapsing Myelitis Without AQP4/MOG Antibodies
by: Ki Hoon Kim, et al.
Published: (2025-08-01) -
Letter to: Real‐World Clinical Experience With Serum MOG and AQP4 Antibody Testing by Live Versus Fixed Cell‐Based Assay
by: Adrian Budhram
Published: (2025-08-01) -
Features of the diagnosis and treatment of patients with AQP-4-positive neuromyelitis optica and MOG antibody disease
by: V. E. Avdeeva, et al.
Published: (2021-11-01) -
Clinical characteristics of patients with GFAP-IgG coexisting with AQP4-IgG or MOG-IgG
by: Qingchen Li, et al.
Published: (2025-07-01)